Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
South Korea launches anti-dumping investigation on alloy steel wire rods from China

South Korea launches anti-dumping investigation on alloy steel wire rods from China

金十金十2026/05/09 07:10
Show original
Golden Ten Data reported on May 9 that on May 7, 2026, the Korea Trade Commission issued an announcement stating that, at the request of Korean manufacturers SeAHBesteel Co., Ltd. and SeAH Changwon Specialty Steel Co., Ltd., an anti-dumping investigation was launched into alloy steel wire rods originating from China. The dumping investigation period is from January 1, 2025 to December 31, 2025, and the injury investigation period is from January 1, 2023 to December 31, 2025. The products involved are alloy steel wire rods, excluding iron, carbon steel, and stainless steel, produced by rolling or forging. Unless separately extended (for up to two additional months), the preliminary ruling is expected to be made within three months of the case filing. Interested parties must register as respondents within three weeks from the date of the announcement.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12